Results 331 to 340 of about 398,911 (393)

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

Lancet Neurology, The, 2009
Kallol Ray Chaudhuri   +1 more
exaly   +2 more sources

Dopaminergic neurons

The International Journal of Biochemistry & Cell Biology, 2005
Dopaminergic neurons of the midbrain are the main source of dopamine (DA) in the mammalian central nervous system. Their loss is associated with one of the most prominent human neurological disorders, Parkinson's disease (PD). Dopaminergic neurons are found in a 'harsh' region of the brain, the substantia nigra pars compacta, which is DA-rich and ...
Shankar J, Chinta, Julie K, Andersen
openaire   +2 more sources

Dopaminergic and non-dopaminergic circling activity of mice

Neuroscience, 1979
Abstract Male ICR albino mice kept in a closed space tend to rotate and have a preferred direction of rotation, which is more often to the left (65%) than to the right (35%). This circling asymmetry was measured with a rotometer in a group of animals following administration of various drugs.
A D, Korczyn, Y, Eshel
openaire   +2 more sources

Future directions in dopaminergic nervous system and dopaminergic agonists

Journal of Medicinal Chemistry, 1981
The physiological and pharmacological roles of pre- and postsynaptic dopamine receptors in modification of neuronal transmission centrally and peripherally will be subjects for intense research during the next decade. As enumerated by Langer, dopamine-sensitive receptors have been described that may inhibit or facilitate release of neurotransmitter ...
J G, Cannon, J P, Long, R, Bhatnagar
openaire   +2 more sources

A dopaminergic mechanism in mania

American Journal of Psychiatry, 1976
The authors present a case study that explores the relationship of dopamine function and manic illness through the use of two drugs with relatively specific effects in stimulating and blocking dopamine receptors--piribedil (ET--495) and pimozide, respectively.
R H, Gerner, R M, Post, W E, Bunney
openaire   +2 more sources

Complications of Dopaminergic Therapy

Disease-a-Month, 2007
both of which can be very difficult to manage. 1-3 The delayed use of l-dopa and then when necessary using the minimal amount of l-dopa required to treat symptoms is now an accepted strategy in the management of Parkinson’s disease. This strategy can minimize and/or forestall the development of the troublesome complications of dopaminergic therapy.
Amy, Kessler, Michael, Rezak
openaire   +2 more sources

Flavonoids as dopaminergic neuromodulators

Molecular Nutrition & Food Research, 2016
ScopeThe present study aimed to characterize and evaluate flavonoids effects on organic cation uptake in neuronal cells.Methods and resultsUptake experiments were conducted using radiolabeled methyl‐4‐phenylpyridinuim ([3H]‐MPP+), in human neuronal dopaminergic cells, SH‐SY5Y.
Meireles, M.   +8 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy